Filing Details
- Accession Number:
- 0001288123-10-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-14 14:21:32
- Reporting Period:
- 2010-09-10
- Filing Date:
- 2010-09-14
- Accepted Time:
- 2010-09-14 14:21:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098972 | Antigenics Inc | AGEN | Biological Products, (No Disgnostic Substances) (2836) | 061562417 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1288123 | M Christine Klaskin | 162 Fifth Ave., Suite 900 New York NY 10010 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-09-10 | 3,333 | $0.93 | 72,821 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2010-09-14 | 1,365 | $0.91 | 71,456 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 195 | Indirect | by Husband |
Footnotes
- Represents settlement of restricted stock awarded on September 10, 2008.
- Represents the sale of shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on September 10, 2008. This sale was made through a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
